Pharmafile Logo
Pharmafocus logo
Advanced Search
Spritam

First 3D-printed drug approved by FDA

August 4, 2015
Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …

News
Toujeo pen

Sanofi launches new insulin Toujeo in the UK

August 4, 2015
Manufacturing and Production, Sales and Marketing Lantus, Sanofi, biosimilars, diabetes, hypoglycaemia, insulin, toujeo

Sanofi’s new insulin Toujeo is now available for clinicians to prescribe in the UK. The French firm is looking to …

News
Hospira logo

Hospira in major US ketorolac recall

August 4, 2015

Hospira is being dogged with manufacturing problems that have led to the recall of millions of vials of its painkilling …

News
Teva image

Teva buys majority stake in genomic analysis firm

August 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis

Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …

News
Shire building

Shire in $300m Foresight acquisition

August 4, 2015
Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye

Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …

News

CSL completes $275m Novartis vaccines acquisition

August 3, 2015
Manufacturing and Production, Sales and Marketing CSL, Novartis, acquisitions, asset swap, vaccines

CSL Limited has finalised its transaction to acquire Novartis’s global influenza vaccine business for $275 million. The move means Novartis …

News
AZ sign

AstraZeneca and Isis Pharma in $65m drugs collaboration

August 3, 2015
Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D

Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …

News
profgrantweb

Sir Malcolm Grant reappointed as NHS England chair

August 3, 2015

Professor Sir Malcolm Grant has been re-appointed as Chair of NHS England from 31 October 2015 for a further three …

Appointment
Lee Heeson

Working Life: Celgene’s Lee Heeson

August 3, 2015
Medical Communications, Sales and Marketing Celgene, Lee Heeson

How did you find your way into your current role?My career has progressed from ‘carrying the bag’ for GlaxoSmithKline in …

Feature
Roche building

Eleven companies accused in Romanian corruption probe

August 3, 2015
Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption

GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …

News
Humira

AbbVie’s Humira receives first European OK for skin condition

August 3, 2015
Sales and Marketing AbbVie, Hidradenitis suppurativa, Humira, adalimumab

The European Commission has approved AbbVie’s Humira as a treatment for moderate-to-severe hidradenitis suppurativa – a chronic condition affecting the …

News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015
Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …

News
Doctor online

UK patients ‘self-diagnose rather than visit GP’

July 31, 2015
Medical Communications GP, General Practice, internet

One in five people in the UK admit to self-diagnosing illnesses rather than making a doctor’s appointment. Research published in …

News
ABPI sign

ABPI consulting on Code of Conduct changes

July 31, 2015
Medical Communications, Sales and Marketing ABPI Code, PMCPA, Prescription Medicines Code of Practice Authority, code of conduct

The division of the ABPI that sets rules governing industry behaviour is consulting on changes to reflect new rules on …

News
healthcare tech

Doctors ‘distrust apps developed by pharma’ – survey

July 31, 2015
Medical Communications France, GPs, Germany, Healthcare Technologies, UK, chronic disease, disease management, healthcare tech

A study of GPs in three European countries show GPs feel there is a role for healthcare technologies in disease …

News
depomedlogo

Depomed rejects Horizon’s latest takeover bid

July 30, 2015
Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers

Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …

News
Aubiago

Sanofi sales boosted by rare disease and multiple sclerosis drugs

July 30, 2015
Manufacturing and Production, Sales and Marketing Genzyme, Oliver Brandicourt, Sanofi, brandicourt, financial results

Sales at pharma giant Sanofi increased by 5% in the second quarter of 2016 to nearly €10 billion, its latest …

News

BMS to trial Opdivo in solid tumours

July 30, 2015
Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours

Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …

News
Daklinza

NICE restricts access to new hepatitis C treatments

July 29, 2015
Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, daklinza, harvoni, hepatits C

NICE has recommended three new treatment options for hepatitis C in draft guidance – but has been criticised for excluding …

News
Takeda oncology

Takeda cancer drug gets EMA boost

July 29, 2015
Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026